Clinical Trials

NCT04439292 | ACTIVE_NOT_RECRUITING | PHASE2
44 participants

Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-12
Start Date:
2016-01-04
Completion:
2023-11-27
Conditions
  • Advanced Lymphoma
  • Advanced Malignant Solid Neoplasm
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Refractory Lymphoma
  • Refractory Malignant Solid Neoplasm
  • Refractory Multiple Myeloma
Interventions
  • DRUG
NCT04356326 | RECRUITING | PHASE3
500 participants

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-12
Start Date:
2021-02-15
Completion:
2029-02-28
Conditions
  • Chronic Hypertension Complicating Pregnancy
  • Pre-Eclampsia
  • Intrauterine Growth Restriction
  • Aspirin
  • Perinatal Death
  • Placental Abruption
Interventions
  • DRUG
No Results Yet
NCT04214249 | ACTIVE_NOT_RECRUITING | PHASE2
49 participants

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-12
Start Date:
2021-02-17
Completion:
2024-11-27
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Secondary Acute Myeloid Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
NCT04117360 | RECRUITING
180 participants

Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-12
Start Date:
2019-09-11
Completion:
2028-03-31
Conditions
  • Dentofacial Abnormalities
  • Dentofacial Deformities
  • Dentofacial Anomalies, Including Malocclusion
  • Malocclusion
  • Malocclusion in Children
  • Dentofacial Disharmony
  • Skeletal Malocclusion
  • Skeletal Malformation
  • Speech Sound Disorder
  • Speech Disorders
Interventions
  • OTHER
No Results Yet
NCT04047641 | RECRUITING | PHASE1/PHASE2
80 participants

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-12
Start Date:
2019-10-22
Completion:
2027-12-31
Conditions
  • Acute Myeloid Leukemia
  • Blasts 20 Percent or More of Bone Marrow Nucleated Cells
  • High Risk Myelodysplastic Syndrome
  • Recurrent Acute Biphenotypic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Recurrent High Risk Myelodysplastic Syndrome
  • Refractory Acute Myeloid Leukemia
  • Refractory High Risk Myelodysplastic Syndrome
Interventions
  • DRUG
No Results Yet
NCT04006249 | COMPLETED | NA
87 participants

Haemochromatosis and Periodontitis

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-12
Start Date:
2010-06-06
Completion:
2011-09-22
Conditions
  • Hemochromatosis
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page